<!DOCTYPE html>
<html lang="en" data-theme="dark">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=no">
  <title>Physics Keypoints</title>
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
  <style>
    /* Theme Variables */
    :root {
      --bg-gradient-start: #0f172a;
      --bg-gradient-mid: #1e1b4b;
      --bg-gradient-end: #3b0764;
      --text-color: #ffffff;
      --card-bg: rgba(0, 0, 0, 0.4);
      --card-border: rgba(139, 92, 246, 0.3);
      --card-hover-border: rgba(139, 92, 246, 0.8);
      --card-hover-shadow: rgba(139, 92, 246, 0.2);
      --accent-color: #a855f7;
      --accent-gradient-start: #22d3ee;
      --accent-gradient-end: #a855f7;
      --btn-primary-bg: #7c3aed;
      --btn-primary-border: #8b5cf6;
      --btn-primary-hover: #8b5cf6;
      --muted-text: #9ca3af;
      --scrollbar-track: rgba(0, 0, 0, 0.2);
      --scrollbar-thumb: rgba(139, 92, 246, 0.5);
      --scrollbar-thumb-hover: rgba(139, 92, 246, 0.8);
      --wave-color-1: #f461c1;
      --wave-color-2: #4579e2;
      --wave-color-3: #3461c1;
      --wave-color-4: #fff;
    }

    /* Light Theme */
    [data-theme="light"] {
      --bg-gradient-start: #f0f9ff;
      --bg-gradient-mid: #e0f2fe;
      --bg-gradient-end: #dbeafe;
      --text-color: #1e293b;
      --card-bg: rgba(255, 255, 255, 0.7);
      --card-border: rgba(139, 92, 246, 0.3);
      --card-hover-border: rgba(139, 92, 246, 0.8);
      --card-hover-shadow: rgba(139, 92, 246, 0.2);
      --accent-color: #8b5cf6;
      --accent-gradient-start: #06b6d4;
      --accent-gradient-end: #8b5cf6;
      --btn-primary-bg: #8b5cf6;
      --btn-primary-border: #7c3aed;
      --btn-primary-hover: #7c3aed;
      --muted-text: #6b7280;
      --scrollbar-track: rgba(0, 0, 0, 0.05);
      --scrollbar-thumb: rgba(139, 92, 246, 0.3);
      --scrollbar-thumb-hover: rgba(139, 92, 246, 0.5);
      --wave-color-1: #d946ef;
      --wave-color-2: #3b82f6;
      --wave-color-3: #2563eb;
      --wave-color-4: #f8fafc;
    }

    /* Base Styles */
    * {
      margin: 0;
      padding: 0;
      box-sizing: border-box;
      font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
    }

    body {
      background: linear-gradient(135deg, var(--bg-gradient-start), var(--bg-gradient-mid), var(--bg-gradient-end));
      color: var(--text-color);
      min-height: 100vh;
      overflow-x: hidden;
      padding-bottom: 2rem;
      transition: background 0.3s ease;
    }

    .container {
      max-width: 95vw;
      margin: 0 auto;
      padding: 2rem 1rem;
    }

    /* Header */
    .header {
      text-align: center;
      margin-bottom: 2rem;
      padding-top: 1rem;
    }

    .title {
      font-size: 2.5rem;
      font-weight: 700;
      margin-bottom: 1rem;
      background: linear-gradient(to right, var(--accent-gradient-start), var(--accent-gradient-end));
      -webkit-background-clip: text;
      background-clip: text;
      color: transparent;
    }

    .subtitle {
      font-size: 1.2rem;
      color: var(--muted-text);
      max-width: 800px;
      margin: 0 auto;
    }

    /* Chapter Styles */
    .chapter {
      background-color: var(--card-bg);
      backdrop-filter: blur(10px);
      -webkit-backdrop-filter: blur(10px);
      border: 1px solid var(--card-border);
      border-radius: 12px;
      padding: 1.5rem;
      margin-bottom: 2rem;
      box-shadow: 0 8px 32px rgba(0, 0, 0, 0.2);
      transition: all 0.3s ease;
    }

    .chapter:hover {
      border-color: var(--card-hover-border);
      box-shadow: 0 12px 40px rgba(0, 0, 0, 0.3);
    }

    .chapter-title {
      font-size: 1.8rem;
      margin-bottom: 1.5rem;
      padding-bottom: 0.5rem;
      border-bottom: 1px solid var(--card-border);
      background: linear-gradient(to right, var(--accent-gradient-start), var(--accent-gradient-end));
      -webkit-background-clip: text;
      background-clip: text;
      color: transparent;
    }

    /* Content Styles */
    .content-section {
      margin-bottom: 1.5rem;
    }

    .section-title {
      font-size: 1.4rem;
      margin-bottom: 1rem;
      color: var(--accent-color);
    }

    .keypoint-list {
      list-style-type: none;
    }

    .keypoint-list li {
      margin-bottom: 0.75rem;
      padding-left: 1.5rem;
      position: relative;
    }

    .keypoint-list li::before {
      content: "•";
      position: absolute;
      left: 0;
      color: var(--accent-color);
      font-weight: bold;
    }

    .sub-list {
      list-style-type: none;
      margin-top: 0.5rem;
      margin-left: 1rem;
    }

    .sub-list li {
      margin-bottom: 0.5rem;
      padding-left: 1.5rem;
      position: relative;
    }

    .sub-list li::before {
      content: "◦";
      position: absolute;
      left: 0;
      color: var(--accent-color);
      font-weight: bold;
    }

    .formula {
      background-color: rgba(0, 0, 0, 0.2);
      padding: 0.5rem 1rem;
      border-radius: 6px;
      margin: 0.5rem 0;
      display: inline-block;
      font-family: 'Courier New', monospace;
    }

    [data-theme="light"] .formula {
      background-color: rgba(0, 0, 0, 0.05);
    }

    /* Wave Divider */
    .wave-divider {
      height: 60px;
      width: 100%;
      position: relative;
      margin: 2rem 0;
    }

    .wave {
      position: absolute;
      width: 100%;
      height: 100%;
      background-repeat: no-repeat;
      background-position: center;
      background-size: cover;
    }

    .wave-1 {
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='0 0 1200 120' preserveAspectRatio='none'%3E%3Cpath fill='%23a855f7' d='M0,0V46.29c47.79,22.2,103.59,32.17,158,28,70.36-5.37,136.33-33.31,206.8-37.5C438.64,32.43,512.34,53.67,583,72.05c69.27,18,138.3,24.88,209.4,13.08,36.15-6,69.85-17.84,104.45-29.34C989.49,25,1113-14.29,1200,52.47V0Z' opacity='.25'%3E%3C/path%3E%3Cpath fill='%23a855f7' d='M0,0V15.81C13,36.92,27.64,56.86,47.69,72.05,99.41,111.27,165,111,224.58,91.58c31.15-10.15,60.09-26.07,89.67-39.8,40.92-19,84.73-46,130.83-49.67,36.26-2.85,70.9,9.42,98.6,31.56,31.77,25.39,62.32,62,103.63,73,40.44,10.79,81.35-6.69,119.13-24.28s75.16-39,116.92-43.05c59.73-5.85,113.28,22.88,168.9,38.84,30.2,8.66,59,6.17,87.09-7.5,22.43-10.89,48-26.93,60.65-49.24V0Z' opacity='.5'%3E%3C/path%3E%3Cpath fill='%23a855f7' d='M0,0V5.63C149.93,59,314.09,71.32,475.83,42.57c43-7.64,84.23-20.12,127.61-26.46,59-8.63,112.48,12.24,165.56,35.4C827.93,77.22,886,95.24,951.2,90c86.53-7,172.46-45.71,248.8-84.81V0Z'%3E%3C/path%3E%3C/svg%3E");
    }

    /* Floating Buttons */
    .floating-btn {
      position: fixed;
      bottom: 30px;
      right: 30px;
      background-color: var(--btn-primary-bg);
      color: white;
      border: none;
      border-radius: 50%;
      width: 60px;
      height: 60px;
      font-size: 20px;
      cursor: pointer;
      box-shadow: 0px 4px 8px rgba(0, 0, 0, 0.3);
      display: flex;
      align-items: center;
      justify-content: center;
      z-index: 1000;
      transition: all 0.3s ease;
    }

    .floating-btn:hover {
      background-color: var(--btn-primary-hover);
      transform: scale(1.05);
    }

    .home-btn {
      position: fixed;
      bottom: 30px;
      left: 30px;
      background-color: var(--btn-primary-bg);
      color: white;
      border: none;
      border-radius: 50%;
      width: 60px;
      height: 60px;
      font-size: 20px;
      cursor: pointer;
      box-shadow: 0px 4px 8px rgba(0, 0, 0, 0.3);
      display: flex;
      align-items: center;
      justify-content: center;
      z-index: 1000;
      transition: all 0.3s ease;
    }

    .home-btn:hover {
      background-color: var(--btn-primary-hover);
      transform: scale(1.05);
    }

    .theme-toggle {
      position: fixed;
      top: 30px;
      right: 30px;
      background-color: var(--btn-primary-bg);
      color: white;
      border: none;
      border-radius: 50%;
      width: 50px;
      height: 50px;
      font-size: 18px;
      cursor: pointer;
      box-shadow: 0px 4px 8px rgba(0, 0, 0, 0.3);
      display: flex;
      align-items: center;
      justify-content: center;
      z-index: 1000;
      transition: all 0.3s ease;
    }

    .theme-toggle:hover {
      background-color: var(--btn-primary-hover);
      transform: scale(1.05);
    }

    /* Table of Contents */
    #table-of-contents {
      display: none;
      position: fixed;
      top: 50%;
      left: 50%;
      transform: translate(-50%, -50%);
      background-color: var(--card-bg);
      box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
      padding: 20px;
      border: 1px solid var(--card-border);
      border-radius: 12px;
      max-width: 80%;
      max-height: 80%;
      overflow: auto;
      z-index: 9999;
      backdrop-filter: blur(10px);
      -webkit-backdrop-filter: blur(10px);
    }

    #table-of-contents h2 {
      color: var(--accent-color);
      margin-bottom: 20px;
      text-align: center;
      font-size: 1.8rem;
      background: linear-gradient(to right, var(--accent-gradient-start), var(--accent-gradient-end));
      -webkit-background-clip: text;
      background-clip: text;
      color: transparent;
    }

    #table-of-contents ul {
      list-style-type: none;
      padding: 0;
      display: grid;
      grid-template-columns: repeat(auto-fill, minmax(200px, 1fr));
      gap: 10px;
    }

    #table-of-contents a {
      display: block;
      margin-bottom: 10px;
      font-size: large;
      color: var(--text-color);
      text-decoration: none;
      padding: 8px 12px;
      border-radius: 8px;
      transition: all 0.2s ease;
    }

    #table-of-contents a:hover {
      background-color: var(--btn-primary-bg);
      color: white;
      transform: translateY(-2px);
    }

    .close-btn {
      position: absolute;
      top: 10px;
      right: 10px;
      background: none;
      border: none;
      color: var(--text-color);
      font-size: 24px;
      cursor: pointer;
    }

    .close-btn:hover {
      color: var(--accent-color);
    }

    /* Custom scrollbar */
    ::-webkit-scrollbar {
      width: 8px;
      height: 8px;
    }

    ::-webkit-scrollbar-track {
      background: var(--scrollbar-track);
      border-radius: 10px;
    }

    ::-webkit-scrollbar-thumb {
      background: var(--scrollbar-thumb);
      border-radius: 10px;
    }

    ::-webkit-scrollbar-thumb:hover {
      background: var(--scrollbar-thumb-hover);
    }

    /* Responsive adjustments */
    @media (max-width: 768px) {
      .title {
        font-size: 2rem;
      }
      
      .subtitle {
        font-size: 1rem;
      }
      
      .chapter-title {
        font-size: 1.5rem;
      }
      
      .section-title {
        font-size: 1.2rem;
      }
      
      #table-of-contents ul {
        grid-template-columns: 1fr;
      }
      
      .floating-btn, .home-btn {
        width: 50px;
        height: 50px;
        font-size: 18px;
      }
      
      .theme-toggle {
        width: 40px;
        height: 40px;
        font-size: 16px;
      }
    }
  </style>
</head>
<body>
  <div id="table-of-contents">
    <button class="close-btn" onclick="toggleTableOfContents()"><i class="fas fa-times"></i></button>
    <h2>Table of Contents</h2>
    <ul>
        <li><a href="#chapter1">Chapter 1</a></li>
        <li><a href="#chapter2">Chapter 2</a></li>
        <li><a href="#chapter3">Chapter 3</a></li>
        <li><a href="#chapter4">Chapter 4</a></li>
        <li><a href="#chapter5">Chapter 5</a></li>
        <li><a href="#chapter6">Chapter 6</a></li>
        <li><a href="#chapter7">Chapter 7</a></li>
        <li><a href="#chapter8">Chapter 8</a></li>
        <li><a href="#chapter9">Chapter 9</a></li>
        <li><a href="#chapter10">Chapter 10</a></li>
        <li><a href="#chapter11">Chapter 11</a></li>
        <li><a href="#chapter12">Chapter 12</a></li>
        <li><a href="#chapter13">Chapter 13</a></li>
        <li><a href="#chapter14">Chapter 14</a></li>
        <li><a href="#chapter15">Chapter 15</a></li>
        <li><a href="#chapter16">Chapter 16</a></li>
        <li><a href="#chapter17">Chapter 17</a></li>
        <li><a href="#chapter18">Chapter 18</a></li>
        <li><a href="#chapter19">Chapter 19</a></li>
        <li><a href="#chapter20">Chapter 20</a></li>
        <li><a href="#chapter21">Chapter 21</a></li>
        <li><a href="#chapter22">Chapter 22</a></li>
        <li><a href="#chapter23">Chapter 23</a></li>
        <li><a href="#chapter24">Chapter 24</a></li>
        <li><a href="#chapter25">Chapter 25</a></li>
        <li><a href="#chapter26">Chapter 26</a></li>
        <li><a href="#chapter27">Chapter 27</a></li>
        <li><a href="#chapter28">Chapter 28</a></li>
      </ul>
  </div>

  <div class="container">
    <div class="header">
      <h1 class="title">Khan's Physics Keypoints</h1>
    </div>

    <div class="chapter" id="chapter1">
        <h1 class="chapter-title">Chapter 1</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>Atomic structure:
    <ul class="bullet1">
    <li>Atom consists of a positively charged nucleus surrounded by a cloud of negatively charged electrons.</li>
    <li>Atomic dimensions: radius of atom ~10<sup>−10</sup> m, radius of nucleus ~10<sup>−15</sup> m.</li>
    </ul>
    </li>
    <li>An atom is specified by the formula: <img alt="" src="data:image/jpeg;base64,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" style="vertical-align: middle;"/> where <span class="italic">X</span> is the symbol for the<a id="GBS.0033.01"></a> element, <span class="italic">A</span> is the mass number (number of protons + neutrons), and <span class="italic">Z</span> is the atomic number (number of protons).</li>
    <li>Classification of atoms:
    <ul class="bullet1">
    <li>Isotopes—atoms with the same <span class="italic">Z</span> but different number of neutrons</li>
    <li>Isotones—atoms with the same number of neutrons but different <span class="italic">Z</span></li>
    <li>Isobars—atoms with the same <span class="italic">A</span> but different <span class="italic">Z</span></li>
    <li>Isomers—atoms with the same <span class="italic">A</span> and same <span class="italic">Z</span> but different nuclear energy states</li>
    </ul>
    </li>
    <li>Nuclear<a id="GBS.0033.02"></a> stability:
    <ul class="bullet1">
    <li>Certain combinations of number of neutrons (n) and protons (p) in the nucleus show more stability than others.</li>
    <li>Most stable nuclei contain even numbers of n and even numbers of p.</li>
    <li>Least stable nuclei contain odd numbers of n and odd numbers of p.</li>
    <li>A high n/p ratio gives rise to β<sup>−</sup> decay, whereas a low n/p ratio can result in electron capture and β<sup>+</sup> decay (to be discussed in <a href="Gibbons9781496397522-ch002.xhtml">Chapter 2</a>).</li>
    </ul><a id="GBS.0033.03"></a>
    </li>
    <li><a id="page_11"></a>Atomic mass:
    <ul class="bullet1">
    <li>u = 1/12 of mass of <img alt="" src="data:image/jpeg;base64,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" style="vertical-align: middle;"/> atom.</li>
    <li>Atomic mass or atomic weight may be expressed in unified atomic mass units, u.</li>
    <li>Number of electrons per gram = <span class="italic">N</span><sub>A</sub> · <span class="italic">Z</span>/<span class="italic">A</span><sub>W</sub>, where <span class="italic">N</span><sub>A</sub> is Avogadro number, <span class="italic">Z</span> is atomic number, and <span class="italic">A</span><sub>W</sub> is atomic weight.</li>
    </ul>
    </li>
    <li>Mass–energy equivalence, <span class="italic">E</span> = <span class="italic">mc</span><sup>2</sup>:
    <ul class="bullet1">
    <li>Energy equivalent of an electron at rest (<span class="italic">E</span><sub>0</sub>) = 0.511<a id="GBS.0033.04"></a> MeV.</li>
    <li>Energy equivalent of 1 u = 931.5 MeV.</li>
    <li>Equivalent masses of particles may also be expressed in units of GeV/<span class="italic">c</span><sup>2</sup> (see <a href="#Gibbons-ch001-fig006">Fig. 1.6</a>).</li>
    </ul>
    </li>
    <li>Atomic energy levels:
    <ul class="bullet1">
    <li>The innermost electron orbit in an atom is the K shell. The next shells are L, M, N, and O. The maximum possible number of electrons in any orbit is given by 2<span class="italic">n</span><sup>2</sup>, where <span class="italic">n</span> is the orbit number.</li>
    <li>Binding energy of electrons in various orbits depends<a id="GBS.0033.05"></a> on the magnitude of the Coulomb force of attraction between the positively charged nucleus and the negatively charged electrons. The closer the orbit is to the nucleus, the greater the binding energy.</li>
    <li>Potential energy is the binding energy with a negative sign.</li>
    </ul>
    </li>
    <li>Nuclear energy levels:
    <ul class="bullet1">
    <li>Nucleons are arranged in discrete energy states of the nucleus.</li>
    <li>Energy level diagram for the decay of <sup>60</sup>Co nucleus<a id="GBS.0034.01"></a> (<a href="#Gibbons-ch001-fig005">Fig. 1.5</a>) shows β particle emission followed by two γ-ray photons emitted per disintegration with energies of 1.17 and 1.33 MeV.</li>
    </ul>
    </li>
    <li>Elementary particles:
    <ul class="bullet1">
    <li>There are 12 fundamental particles of matter: 6 quarks and 6 leptons. Correspondingly, there are six quarks and six leptons of antimatter. All these particles are called fermions. In addition, there are 13 messenger particles, called bosons,<a id="GBS.0034.02"></a> that mediate the 4 forces of nature.</li>
    <li>Fermions have noninteger spin; bosons have integer spin.</li>
    <li>The Higgs field permeates all space and is responsible for giving mass properties to matter. The messenger particle for the Higgs field is the Higgs boson.</li>
    </ul>
    </li>
    <li>Forces of nature:
    <ul class="bullet1">
    <li>There are four forces of nature. In order of their strengths, they are strong nuclear, electromagnetic, weak nuclear, and gravitational.</li>
    <li><a id="GBS.0034.03"></a>All forces of nature are mediated by specific messenger particles, the bosons.</li>
    </ul>
    </li>
    <li>Electromagnetic radiation:
    <ul class="bullet1">
    <li>Electromagnetic radiations are characterized by oscillating electric and magnetic fields, always perpendicular to each other and to the direction of their energy propagation.</li>
    <li>Wavelength (λ), frequency (ν), and velocity (<span class="italic">c</span>) of electromagnetic waves are related by <span class="italic">c</span> = νλ.</li>
    <li>Quantum model relates<a id="GBS.0034.04"></a> energy of a photon with its frequency of oscillation by <span class="italic">E</span> = <span class="italic">h</span>ν, where <span class="italic">h</span> is Planck’s constant.</li>
    <li>If λ is given in meters, the photon energy in electron volts is given by <span class="italic">E</span> = (1.24 × 10<sup>−6</sup>)/λ.</li>
    </ul>
    </li>
    </ul>
    </div>
        </div>
        

    
        <div class="chapter" id="chapter2">
        <h1 class="chapter-title">Chapter 2</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>Radioactivity:
    <ul class="bullet1">
    <li>Emission of radiation<a id="GBS.0060.04"></a> from a nucleus in the form of particles, γ-rays, or both is called radioactivity.</li>
    <li>Activity <span class="italic">A</span> of a radioactive element is the rate of disintegration or decay and is given by <span class="italic">A</span> = <span class="italic">A</span><sub>0</sub> <span class="italic">e</span><sup>−</sup>λ<sup><span class="italic">t</span></sup>, where <span class="italic">A</span> is activity at time <span class="italic">t</span>, <span class="italic">A</span><sub>0</sub> is activity at the start of time <span class="italic">t</span>, and λ is the disintegration constant.</li>
    <li>Half-life <span class="italic">T</span><sub>1/2</sub> and λ are related by <span class="italic">T</span><sub>1/2</sub> = 0.693/λ.</li>
    <li>Average or mean life <span class="italic">T</span><sub>a</sub> = 1/λ = 1.44 <span class="italic">T</span><sub>1/2</sub>.</li>
    <li>The SI<a id="GBS.0060.05"></a> unit for activity is becquerel (Bq). 1 Bq = 1 dps.</li>
    <li>A practical unit of activity is curie (Ci). 1 Ci = 3.7 × 10<sup>10</sup> dps.</li>
    <li>Activity of 1 g of radium is 0.975 Ci.</li>
    </ul>
    </li>
    <li>All of the naturally occurring radioactive elements have been grouped together into three series: uranium, actinium, and thorium. The rest (<span class="italic">Z</span> = 93 to 118) are produced artificially.</li>
    <li>Radioactive equilibrium:
    <ul class="bullet1">
    <li>If the half-life of the parent<a id="GBS.0061.01"></a> nuclide is larger than that of the daughter nuclide, a condition of equilibrium occurs after a certain amount of time. At equilibrium, the ratio of daughter activity to parent activity becomes constant.</li>
    <li>Transient equilibrium occurs when the half-life of the parent (<span class="italic">T</span><sub>1</sub>) is not much longer than that of the daughter (<span class="italic">T</span><sub>2</sub>) (e.g., decay of <sup>99</sup>Mo to <sup>99m</sup>Tc). At transient equilibrium, the daughter activity<a id="GBS.0061.02"></a> <span class="italic">A</span><sub>2</sub> and the parent activity <span class="italic">A</span><sub>1</sub> are related by <span class="italic">A</span><sub>2</sub> = <span class="italic">A</span><sub>1</sub> × <span class="italic">T</span><sub>1</sub>/(<span class="italic">T</span><sub>1</sub> − <span class="italic">T</span><sub>2</sub>).</li>
    <li>Secular equilibrium occurs when the half-life of the parent is much longer than that of the daughter (e.g., decay of <sup>226</sup>Ra to <sup>222</sup>Rn). At secular equilibrium, <span class="italic">A</span><sub>2</sub> ≈ <span class="italic">A</span><sub>1</sub>.</li>
    </ul>
    </li>
    <li>Modes of decay:
    <ul class="bullet1">
    <li>α particles are helium nuclei and are emitted by high-atomic-number radionuclides (<span class="italic">Z</span> &gt; 82).</li>
    <li>β<sup>−</sup> particle is a negatively charged electron (negatron)<a id="GBS.0061.03"></a> emitted from a nucleus.</li>
    <li>β<sup>+</sup> particle is a positively charged electron (positron) emitted from a nucleus.</li>
    <li>β particle does not exist as such in the nucleus but is emitted at the instance of a neutron or a proton decay in the nucleus:</li>
    </ul>
    </li>
    </ul>
    <p class="image" id="Gibbons-ch002-unequat046"><img alt="" src="data:image/jpeg;base64,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"/><a id="GBS.0061.04"></a></p>
    <ul class="keypoint-list">
    <li>β particles are emitted with a spectrum of energies, ranging from zero to a maximum. They share the available kinetic energy with the accompanying neutrino.</li>
    <li>The average energy of β particles is about one-third of the maximum energy.</li>
    <li>Electron capture is a process in which a nucleus captures an orbital electron, thus transforming one of its protons into a neutron:</li>
    </ul>
    <p class="image" id="Gibbons-ch002-unequat047"><img alt="" src="data:image/jpeg;base64,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"/><a id="GBS.0061.05"></a></p>
    <ul class="keypoint-list">
    <li>Electron capture creates a vacancy in the electron orbit involved that, when filled by an outer orbit electron, gives rise to characteristic x-rays (fluorescent radiation) and/or Auger electrons. The process is likened to “internal photoelectric effect.”</li>
    <li>Internal conversion is a process in which a nucleus in the excited state transfers its excess energy to one of the orbital electrons, causing<a id="GBS.0062.01"></a> it to be ejected from the orbit. The ejected electron creates a vacancy in the involved shell and, as mentioned in the electron capture process, causes the emission of characteristic x-rays (fluorescent radiation) or Auger electrons.</li>
    <li>Fluorescent yield is <span class="italic">Z</span> dependent, increasing from lower <span class="italic">Z</span> to higher <span class="italic">Z</span>.</li>
    <li>Isomeric transition involves an excited nucleus in the metastable state decaying to the ground<a id="GBS.0062.02"></a> state. Example: <sup>99m</sup>Tc decaying to <sup>99</sup>Tc with a half-life of 6 hours.</li>
    </ul>
    <ul class="keypoint-list">
    <li><a id="page_28"></a>Nuclear reactions:
    <ul class="bullet1">
    <li>Nuclear reactions can be produced by bombarding heavier nuclides with lighter nuclides or particles.</li>
    <li>Examples of bombarding particles are α particles, protons, neutrons, deuterons, and γ-ray photons.</li>
    <li>The photodisintegration process is responsible for contamination of the high-energy x-ray beams generated<a id="GBS.0062.03"></a> by linear accelerators.</li>
    <li>Radioactive sources used in radiation therapy are produced by bombarding nuclides in nuclear reactors or particle accelerators.</li>
    <li>Nuclear fission is a process of splitting high <span class="italic">Z</span> nucleus into two lower <span class="italic">Z</span> nuclei. The process results in the release of a large amount of energy. Example: fission of <sup>235</sup>U nucleus by bombarding it with thermal neutrons (i.e., neutrons of energy<a id="GBS.0062.04"></a> &lt; 0.025 eV). A chain reaction is possible with a critical mass of fissionable material.</li>
    <li>Nuclear fusion is the reverse of nuclear fission—lighter nuclei are fused together into heavier ones. Again, a large amount of energy is released in the process.</li>
    <li>Fusion of hydrogen nuclei into helium nuclei is the source of our sun’s energy.</li>
    </ul>
    </li>
    </ul>
    </div>
        </div>
        

    
        <div class="chapter" id="chapter3">
        <h1 class="chapter-title">Chapter 3</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>The x-ray tube:
    <ul class="bullet1">
    <li>X-ray tube is highly evacuated to prevent<a id="GBS.0080.03"></a> electron interactions with air.</li>
    <li>Choice of tungsten for filament (cathode) and target (anode) is based on its having a high melting point (3,370°C) and a high atomic number (<span class="italic">Z</span> = 74), which is needed to boost the efficiency of x-ray production.</li>
    <li>Heat generated in the target must be removed to prevent target damage, for example, using a copper anode to conduct heat away, a rotating anode, fans, and<a id="GBS.0080.04"></a> an oil bath around the tube. The function of the oil bath is to provide electrical insulation as well as heat absorption.</li>
    <li>The function of a hooded anode (tungsten + copper shield around target) is to prevent stray electrons from striking the nontarget components of the tube and absorbing bremsstrahlung as a result of their interactions.</li>
    <li>Apparent focal spot size <span class="italic">a</span> is given as follows: <span class="italic">a</span> = <span class="italic">A</span> sin<a id="GBS.0080.05"></a> θ, where <span class="italic">A</span> is the side of actual focal spot at an angle θ perpendicular to the direction of the electron beam (<a href="#Gibbons-ch003-fig002">Fig. 3.2</a>). The apparent focal spot size ranges from 0.1 × 0.1 to 2 × 2 mm<sup>2</sup> for imaging, and 5 × 5 to 7 × 7 mm<sup>2</sup> for orthovoltage therapy tubes.</li>
    <li>Peak voltage on an x-ray tube = √2 · line voltage · transformer turn ratio.</li>
    <li>Rectifiers conduct electrons in one direction only and can withstand<a id="GBS.0081.01"></a> reverse voltage up to a certain magnitude. Full-wave rectification increases effective tube current.</li>
    <li>X-ray output per mAs can be substantially increased by applying three-phase power to the x-ray tube. A three-phase, six-pulse generator delivers high-voltage pulses with a voltage ripple of 13% to 25%.</li>
    <li>A three-phase, 12-pulse generator is capable of providing high-voltage pulses to the x-ray tube<a id="GBS.0081.02"></a> with much less ripple (3% to 10%).</li>
    <li>A high-frequency generator provides nearly constant high-voltage potential (with a ripple of &lt;2%). Consequently, it generates higher x-ray output per mAs and shorter exposure times.</li>
    </ul>
    </li>
    <li>X-ray production:
    <ul class="bullet1">
    <li>X-rays are produced by two different mechanisms: bremsstrahlung and characteristic x-ray emission.</li>
    <li>Bremsstrahlung x-rays have a spectrum of energies. The maximum<a id="GBS.0081.03"></a> energy is numerically equal to the peak voltage. Average energy is about one-third of the maximum energy.</li>
    <li>Characteristic x-rays have discrete energies, corresponding to the energy level difference between shells involved in the electron transition.</li>
    <li>The higher the energy of electrons bombarding the target, the more forward the direction of x-ray emission.</li>
    <li>The efficiency of x-ray production is proportional<a id="GBS.0081.04"></a> to the atomic number <span class="italic">Z</span> of the target and the voltage applied to the tube. The efficiency is less than 1% for x-ray tubes operating at 100 kVp (99% of input energy is converted into heat). The efficiency improves considerably for high-energy accelerator beams (30% to 95%, depending upon energy).</li>
    </ul>
    </li>
    <li>Operating characteristics:
    <ul class="bullet1">
    <li>The output (exposure rate) of an x-ray machine is very sensitive to the<a id="GBS.0081.05"></a> filament current. The output increases proportionally with tube current and approximately with the square of the tube voltage.</li>
    </ul>
    </li>
    </ul>
    </div>
        </div>
        

    
        <div class="chapter" id="chapter4">
        <h1 class="chapter-title">Chapter 4</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>Kilovoltage,<a id="GBS.0114.04"></a> supervoltage, Van de Graaff, betatrons, and cobalt-60 units have been largely replaced by linear accelerators. A few of these machines, however, are still in use, for example, endocavitary x-rays (for rectal cancers), superficial x-rays (for skin cancers), and cobalt-60 γ-rays (for head and neck cancers).</li>
    <li>Linear accelerator:
    <ul class="bullet1">
    <li>Energized by microwaves of frequency ~3,000 MHz.</li>
    <li>Major components: power<a id="GBS.0114.05"></a> supply, modulator (pulse-forming network), hydrogen thyratron (switch tube), magnetron (microwave generator) or klystron (microwave <a id="page_59"></a>amplifier), waveguide system (to conduct microwaves), electron gun, accelerator structure, circulator (to prevent reflected microwaves from reaching the microwave power source—magnetron or klystron), focusing coils, bending magnets, automatic frequency control (AFC),<a id="GBS.0115.01"></a> and treatment head.</li>
    </ul>
    </li>
    <li>Treatment head:
    <ul class="bullet1">
    <li>Shielded by lead, tungsten, or lead–tungsten alloy.</li>
    <li>Tungsten target (in position for the x-ray mode). Focal spot size ~2 to 3 mm in diameter.</li>
    <li>Dual scattering foil (in position for the electron mode). The function of scattering foil is to spread the electron beam as well as make it uniform in cross section.</li>
    <li>Flattening filter (in position for the x-ray mode).<a id="GBS.0115.02"></a> The function of the flattening filter is to make the x-ray beam intensity uniform across the field.</li>
    <li>Primary collimator provides a fixed maximum aperture for the x-ray beam.</li>
    <li>Secondary collimators (x-ray jaws) are movable and provide variable rectangular field sizes.</li>
    <li>Monitor chambers (dual flat ion chambers) monitor dose delivery (when calibrated) and beam flatness.</li>
    <li>Electron applicators (in the<a id="GBS.0115.03"></a> electron mode) collimate electron beam close to the patient surface (~5 cm away). They are interlocked for the choice of electron mode as well as electron beam energy.</li>
    </ul>
    </li>
    <li>Microtron:
    <ul class="bullet1">
    <li>Microtron combines the principle of linear accelerator and cyclotron.</li>
    <li>Beam characteristics are similar to those of linear accelerator. The difference is primarily in the electron beam acceleration technology and electron<a id="GBS.0115.04"></a> transport. Treatment heads are similarly equipped.</li>
    </ul>
    </li>
    <li>Penumbra: a dose transition region near the borders of the field. Penumbras are of three kinds:
    <ul class="bullet1">
    <li>Geometric penumbra is due to the finite dimensions of the source (or focal spot). Its width is proportional to source diameter. It increases with increase in SSD and depth and decreases with increase in SDD.</li>
    <li>Transmission penumbra is caused by variable<a id="GBS.0115.05"></a> transmission of beam through nondivergent collimator edge.</li>
    <li>Physical penumbra is the spread of dose distribution near field borders and is usually specified by the lateral width of isodose levels (e.g., 90% to 20%). It is influenced by geometric penumbra, beam energy, and the lateral transport of electrons in the tissues.</li>
    </ul>
    </li>
    <li>Neutron beams are generated in D–T generators (deuterons bombarding tritium<a id="GBS.0116.01"></a> target) or cyclotrons (deuterons bombarding beryllium target).</li>
    <li>Proton, negative pion, and heavy particle beams are produced in cyclotrons or linear accelerators by bombarding appropriate targets with appropriate particles.</li>
    <li>Protons and heavier charged particles exhibit Bragg peak. The Bragg peak for negative pions is accentuated because of pion capture by nuclei—a process called star formation.</li>
    </ul>
    </div>
        </div>
        

    
        <div class="chapter" id="chapter5">
        <h1 class="chapter-title">Chapter 5</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>Charged particles are directly ionizing radiation. Uncharged particles such as neutrons and photons are indirectly ionizing—they liberate directly ionizing particles that are responsible for producing<a id="GBS.0146.02"></a> ionization and excitation of atoms.</li>
    <li>Photon beam attenuation is characterized by attenuation coefficient μ. For a narrow monoenergetic beam, the attenuation is given by <span class="italic">I</span>(<span class="italic">x</span>) = <span class="italic">I</span><sub>0</sub>e<sup>−</sup><sup><span class="italic">μx</span></sup>.</li>
    <li>HVL and attenuation coefficient are related by HVL = 0.693/μ.</li>
    </ul>
    <ul class="keypoint-list">
    <li><a id="page_77"></a>μ, μ<sub>tr</sub>, and μ<sub>en</sub> are parameters that, respectively, characterize photon beam attenuation, energy transfer, and energy absorption as the beam traverses<a id="GBS.0146.03"></a> a medium.</li>
    <li>Photon beams interact with matter through five major processes: coherent scattering, photoelectric effect, Compton effect, pair production, and photodisintegration.</li>
    <li>Coherent scattering involves no net loss of energy. This type of interaction is probable with low-energy photons and high-<span class="italic">Z</span> materials—not important for radiation therapy beams interacting with body tissues, which have low <span class="italic">Z</span><a id="GBS.0146.04"></a>.</li>
    <li>Photoelectric effect involves complete absorption of photon energy by the atom and transferring that energy to an orbital electron, which is ejected. The process results in the emission of photoelectron, characteristic x-rays (fluorescent radiation), and Auger electrons.<ul class="bullet1">
    <li>Photoelectric probability varies as 1/<span class="italic">E</span><sup>3</sup> and <span class="italic">Z</span><sup>3</sup>.</li>
    <li>Photoelectric effect in water (or soft tissue) is predominant for photon energies<a id="GBS.0146.05"></a> of up to 25 keV (average energies of x-ray beams generated at potentials up to 75 kVp).</li>
    </ul>
    </li>
    <li>Compton effect involves photon interaction with a “free electron” (loosely bound electron—binding energy much less than the incident photon energy).<ul class="bullet1">
    <li>Compton interaction probability in water increases with photon energy from 10 to 150 keV. It then decreases with further increase in energy. However, it is the<a id="GBS.0147.01"></a> predominant mode of interaction in water for 30 keV to 24 MeV. That includes all x-ray beams used in radiation therapy.</li>
    <li>Compton probability is almost independent of <span class="italic">Z</span>. It depends on electron density (number of electrons per cubic centimeter).</li>
    <li>Maximum energy of a photon scattered at 90 degrees is 0.511 MeV, and at 180 degrees it is 0.255 MeV.</li>
    </ul>
    </li>
    <li>Pair production involves a high-energy photon interaction<a id="GBS.0147.02"></a> with the electromagnetic field of a nucleus. Photon energy is all used up in creating a pair of electron (e<sup>−</sup>) and positron (e<sup>+</sup>) and providing it with kinetic energy.<ul class="bullet1">
    <li>The threshold energy for pair production is 1.02 MeV—just enough to create the electron–positron pair.</li>
    <li>Pair production probability increases slowly with energy beyond 1.02 MeV. It increases from about 6% at 4 MeV to 20% at 7 MeV (average<a id="GBS.0147.03"></a> energies of 12 to 21 MV x-ray beams).</li>
    <li>Pair production coefficient varies approximately as <span class="italic">Z</span><sup>2</sup> per atom, <span class="italic">Z</span> per electron, and <span class="italic">Z</span> per gram.</li>
    <li>The reverse of pair production process is the electron–positron annihilation, giving rise to two photons each of 0.511 MeV ejected in the opposite direction.</li>
    </ul>
    </li>
    <li>Photodisintegration involves a photon creating a nuclear reaction (described in Section 2.8F). In most<a id="GBS.0147.04"></a> cases, it results in the emission of a neutron. The process is only important at high photon energies and is responsible for neutron contamination of therapy beams of energy greater than 10 MV.</li>
    <li>Particle interactions<ul class="bullet1">
    <li>Charged particles interact primarily by ionization and excitation. Radiative collisions (bremsstrahlung) are possible but more likely for electrons than heavier charged particles.</li>
    <li><a id="GBS.0147.05"></a>All charged particles exhibit a Bragg peak near the end of their range. The Bragg peak is not observed in electron beams because of excessive scattering and smearing of the Bragg peaks.</li>
    <li>Neutrons interact by ejecting recoil protons or producing nuclear disintegrations.</li>
    <li>Lead is an efficient absorber of x-rays but not of neutrons. The most efficient absorber of neutrons is a hydrogenous material such<a id="GBS.0148.01"></a> as water, paraffin wax, and polyethylene.</li>
    </ul>
    </li>
    </ul>
    </div>
        </div>
        

    
        <div class="chapter" id="chapter6">
        <h1 class="chapter-title">Chapter 6</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>Exposure is a measure of ionization in air produced by photons.
    <ul class="bullet1">
    <li>The unit of exposure is the roentgen (R): 1 R = 2.58 ×<a id="GBS.0174.03"></a> 10<sup>−4</sup> C/kg of air.</li>
    <li>The free-air ionization chamber is a standard ion chamber that can measure exposure for relatively low-energy photon beams in which electronic equilibrium can be achieved in free air. It measures exposure in accordance with its definition.</li>
    </ul></li>
    <li>Chambers that require calibration by a standard chamber are called secondary chambers (e.g., Farmer or Farmer-type chambers).</li>
    <li>Exposure calibration<a id="GBS.0174.04"></a> factor of a secondary ion chamber converts its reading (corrected for conditions different than those specified in the chamber calibration certificate) into exposure in roentgens in dry air in the absence of a chamber.</li>
    <li>Farmer or Farmer-type chambers can be used to calibrate all beam energies used in radiotherapy. Various calibration protocols using ion chamber dosimetry are discussed in <a href="Gibbons9781496397522-ch008.xhtml">Chapter 8</a><a id="GBS.0174.05"></a>.</li>
    <li>The electrometer is a charge-measuring device. The most commonly used electrometers are negative-feedback operational amplifiers. They are connected to the ion chamber through a shielded cable.</li>
    <li>Extrapolation and parallel-plate (or plane-parallel) chambers are suitable for measuring surface dose or dose in the buildup region where dose gradients are high.</li>
    <li>Ion recombination correction depends on<a id="GBS.0175.01"></a> chamber design, bias voltage, beam type (photons or electrons), beam intensity, and whether the beam is pulsed, pulse scanned, or continuous (as in cobalt-60).</li>
    <li>If the chamber reading changes with change in polarity of its bias voltage, it is exhibiting polarity effect. Polarity effect should be less than 0.5% for a well-designed chamber.</li>
    <li>For a chamber that is open to the outside temperature and<a id="GBS.0175.02"></a> pressure of air, the reading must be corrected by a factor given by <a href="#Gibbons-ch006-equat006">Equation 6.6</a>. This correction factor is relative to the environmental conditions specified at the standards laboratory.</li>
    </ul>
    </div>
        </div>
        

    
        <div class="chapter" id="chapter7">
        <h1 class="chapter-title">Chapter 7</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>Quality of x-ray beams is specified by kVp, filtration, and HVL (for diagnostic, superficial, and orthovoltage beams); and MV and percent depth dose in water (for megavoltage x-rays).</li>
    <li>Quality of cobalt-60 beams is designated simply as cobalt-60 because it is known that<a id="GBS.0191.01"></a> they have the same energy, namely γ-rays of 1.17 and 1.33 MeV.</li>
    <li>HVL must be measured under “good geometry” conditions: a narrow beam and a large distance between absorber and detector in order to avoid measurement of scattered radiation.</li>
    <li>Peak voltage (kVp) applied to an x-ray generator can be measured directly (e.g., voltage divider, sphere gap method) or indirectly (e.g., fluorescence, attenuation,<a id="GBS.0191.02"></a> or a penetrameter device such as an Adrian–Crooks cassette).</li>
    <li>Peak energy (MV) of a megavoltage x-ray beam can be measured directly by scintillation spectrometry or by photoactivation of appropriate foils (e.g., PAR method). Most commonly used methods, however, are indirect, such as comparing measured percent depth dose distribution in water with published data.</li>
    <li>Effective or equivalent energy of<a id="GBS.0191.03"></a> an x-ray beam is the energy of a monoenergetic photon beam that has the same HVL as the given beam.</li>
    <li>Energy spectrum of an x-ray beam can be measured by scintillation spectrometry. The spectrum may be displayed in terms of photon fluence per unit energy interval as a function of photon energy.</li>
    </ul>
    </div>
        </div>
        

    
        <div class="chapter" id="chapter8">
        <h1 class="chapter-title">Chapter 8</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>Absorbed dose (or simply dose) is the energy absorbed per unit mass.<ul class="keypoint-list">
    <li>The SI unit of dose is gray (Gy). 1 Gy = 100 cGy = 100 rad = 1 J/kg.</li>
    <li>Roentgen-to-rad conversion factor for air (<span class="italic">f</span><sub>air</sub>) = 0.876 rad/R for all x and γ radiation.</li>
    <li>For any medium, the roentgen-to-rad conversion factor, <span class="italic">f</span><sub>med</sub> = 0.876 × (ratio of average mass energy absorption coefficient for medium to that for air).</li>
    <li>For<a id="GBS.0254.04"></a> low-energy x-ray beams such as orthovoltage and superficial, the absorbed dose in bone is two to four times the absorbed dose in soft tissue for the same exposure because of the significant probability of the photoelectric effect, which is dependent on <span class="italic">Z</span><sup>3</sup> (<span class="italic">Z</span><sub>eff</sub> for bone is 12.3 and for soft tissue it is 7.6).</li>
    <li>For megavoltage photon beams, the absorbed dose in bone is slightly less than that in<a id="GBS.0254.05"></a> soft tissue because of the predominance of the Compton effect, which, although independent of <span class="italic">Z</span>, is dependent on the number of electrons per gram. As shown in <a href="Gibbons9781496397522-ch005.xhtml#Gibbons-ch005-tbl001">Table 5.1</a>, bone has slightly fewer numbers of electrons per gram than soft tissue.</li>
    </ul>
    </li>
    <li><a id="page_134"></a>Kerma is the sum of kinetic energies of electrons and positrons released by photons in a medium per unit mass.<ul class="keypoint-list">
    <li>The unit of kerma is the same as that of<a id="GBS.0255.01"></a> dose, namely, Gy.</li>
    <li>Kerma pertains only to photon beams.</li>
    <li>Kerma is proportional to photon energy fluence. It is maximum at the surface and decreases exponentially with depth.</li>
    <li>For megavoltage beams, dose is less than kerma at the surface. It builds up to a maximum value at a certain depth, depending upon energy. With a further increase in depth it achieves a transient electronic equilibrium and decreases<a id="GBS.0255.02"></a> exponentially. In the transient equilibrium region, dose exceeds kerma but decreases at the same rate as kerma.</li>
    </ul>
    </li>
    <li>Calibration in air<ul class="keypoint-list">
    <li>Low-energy beams up to cobalt-60 may be calibrated in air in terms of exposure in roentgens. Exposure is then converted into “dose in free space”—dose to a small mass of tissue just sufficient to provide electronic equilibrium. By multiplying “dose in free space”<a id="GBS.0255.03"></a> with backscatter factor, one obtains <span class="italic">D</span><sub>max</sub> (dose at the depth of maximum dose in a water phantom). This topic is further discussed in <a href="Gibbons9781496397522-ch009.xhtml">Chapter 9</a>.</li>
    </ul>
    </li>
    <li>Bragg–Gray cavity theory<ul class="keypoint-list">
    <li>The principle of Bragg–Gray (B-G) cavity theory is that the ionization produced in a gas-filled cavity (e.g., air cavity of an ion chamber) placed in a medium is related to the energy absorbed in the medium surrounding the cavity.<a id="GBS.0255.04"></a> This relationship, in its simplest form, involves the ionization charge produced per unit mass of cavity gas and the ratio of average mass stopping power of electrons traversing the medium to that of electrons crossing the cavity gas. Any perturbation in electron fluence caused by the presence of the cavity needs to be corrected.</li>
    <li>Whereas exposure in roentgens cannot be measured accurately for<a id="GBS.0255.05"></a> photon beams of energy above 3 MeV (practically not above cobalt-60), the B-G cavity theory has no limitation of energy or the type of ionizing radiation in the measurement of absorbed dose.</li>
    <li>All recent calibration protocols (TG-21, TG-51, and IAEA TRS-398) use B-G cavity theory.</li>
    </ul>
    </li>
    <li>The effective point of measurement for a cylindrical chamber of internal radius <span class="italic">r</span> irradiated by a photon beam is displaced<a id="GBS.0256.01"></a> by 0.6 <span class="italic">r</span> from its center and toward the source. For electron beams, this displacement is approximately 0.5 <span class="italic">r</span>.</li>
    <li>For a plane-parallel chamber, the effective point of measurement is at the front surface of the cavity.</li>
    <li>TG-21<ul class="keypoint-list">
    <li>This AAPM calibration protocol (published in 1983) has been superseded by the AAPM TG-51 protocol.</li>
    <li>TG-21 requires chamber calibration in terms of air kerma or <span class="italic">N</span><sub><span class="italic">x</span></sub> (exposure calibration<a id="GBS.0256.02"></a> factor for cobalt-60 beam). <span class="italic">N</span><sub>gas</sub> (dose to cavity air per unit charge of ionization) is calculated from <span class="italic">N</span><sub><span class="italic">x</span></sub> and other factors related to chamber design.</li>
    <li>Basic equations for the calibration of photon and electron beams are given by <a href="#Gibbons-ch008-equat045">Equations 8.45</a> and <a href="#Gibbons-ch008-equat046">8.46</a>, respectively.</li>
    </ul>
    </li>
    <li>TG-51<ul class="keypoint-list">
    <li>The major difference between TG-51 and TG-21 is the chamber calibration, which is based on absorbed dose to water instead<a id="GBS.0256.03"></a> of exposure in air. <img alt="" src="data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wCEAAEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAv/AABEIAB4ALwMBIgACEQEDEQH/xAAZAAACAwEAAAAAAAAAAAAAAAAHCAAGCQr/xAAjEAADAAMBAQACAwEBAQAAAAAEBQYCAwcIAQAJExQVFxYS/8QAFQEBAQAAAAAAAAAAAAAAAAAAAAH/xAAZEQEAAgMAAAAAAAAAAAAAAAAAEfASMdH/2gAMAwEAAhEDEQA/AO/j8n5hl+zSM7yp9J8K774oBzO9FeeuS9d790Lmqw5yEP6a5jLVvFoLdwmnViE/+fZuK+Hr+qnc9oDkdBUJqyFnlyH4HtJAJDNvcul8I/YB418133Nt+FVJeke5eYQ41poy2gV02p2dnj6XuUrtZo2OhvH1ivl0R1SJtBVzT5kCcI1VMsGS3AkYksasH+seq/Vt0p5JEqhazp7adIszFZjPNOgi4bSdsU6a62cDgNiwBXbvSQhjUq9Ue8sHALn6AMNOytrTy4gsvVy+UY3RuCPQwh+RegeKebumO8zdwjPRaduw5FguoZwPEUpaXKxJvd+XaKrI5oORkOZ0Ld/KtL5uGtvwP6N/XjN9speyMlqjn6//AKd595DxznNgYOQus/KNXxh/1ZlG9P4VpWJCxgGaH709fRTqxO4gf8ul52AGaxcJK0nCYJtL5LdOWvY50Zqi/wCadu9TcH9RUO8so37SID+R/eDnUMAuRfUZa5yluXPnaf37np1SuPVDdKsNIC3Trk5vS1B7PyfiCzXcKZfzyItKVrS7u2mME012Dk5ge0KU5u3pOiSEZZvHajKW/wB1XzXhhFKQ2j7MApOH1HnGsKwpLJ9NtRukTba8psW9/Cqah/M7pRoYZRA7lee/eUKVoQ0refBpEpRYS00qXswFYthJEnrV7AmYeKN54AZme4fWQtHNNfYGftnvttYcM6FG8uK41wzlvLr15WcYazj46Equ62HQ3gU/J9RoL1BrpN3R4hKNg9kxdx+uL0ElalOGP/zuRtN4j7d5z/ZFG2nEJUyp8Fde6rY+nuixCR7ELdvm/wBasOP9G429sVaSvsphgdybs6HqZ1VSpYFTa0CvocyMYGnQz2kMNruB+T8LlwivbKCwtfYHnngEXfWMSkG5T23ufaSI08YIg2YTlRHNeXSxpBYjDBbvo7i4eV6k0MXSYUPyN8s3Gf5hJ4B9i8a9Yu+nxnaQbNvnbMOO+me7cMnehnhIkZHR0PNaf6uAcOBZJStmxXk+wIYc2qyp+eUrjKaHdtBp5T/ZyVDEo7zvHG9Lv+s40PQF9j0uMh+dVpqer3J/u2C5y3uHspLT5i4YdzEDBtujWpxjeHazlO2IdY7mj0vcpR7Fldc+ZZkcvziFzVjQ8llvPlexplyOBsaifS0S5mmarG8rYyAZnyZ6KHWFuC2755f6HjsFx/foVG3GtfFUYQL3Nfsl57QlplG+CpZ+lacj9E9HKm3jJfpZJq3zJ0x5y3oHE2GwbQUDn1HbQTVJuRqwCigWy+TsDwDCgEmkxlouu3GELwSGAfxaw3hjbjl+JOBuIBm3ThsJCxM169eovEXdlno+Fa9WvDf81/y44YfM/mPxYj/F3nhjX43G+I+Y0mv0gp9XjnDsTR/6fZ03PfnNh3YWOrZj/TUlJNzNmzmx/utKzq6GmqTRNzmibkl0H9hPvvk/63+BZehuxyvQ7CU+V09F6k3M182xoMmlFkV/VIz01NRJrdYGnWGRkRsxZbSPmf8ADhrF2fM89moj/9k=" style="vertical-align: middle;"/> is the absorbed dose-to-water calibration factor for the chamber determined in a cobalt-60 beam under reference conditions.</li>
    <li>Beam quality for photon beams is specified by percent depth dose for the photon component of the beam at 10 cm depth in water [%dd(10)<sub><span class="italic">x</span></sub>].</li>
    <li>Beam quality for the purpose of electron<a id="GBS.0256.04"></a> beam calibration is specified by the depth of 50% dose in water (<span class="italic">R</span><sub>50</sub>).</li>
    <li><a id="page_135"></a>Calibration of a photon beam is performed at 10 cm depth in water and then converted to dose at the reference depth of maximum dose (<span class="italic">D</span><sub>max</sub>) by using percent depth dose or tissue maximum ratio at 10 cm depth. Sensitivity of monitor chambers is adjusted to give <span class="italic">D</span><sub>max</sub>/MU close to unity for a 10 × 10-cm field size at SSD = 100 cm<a id="GBS.0256.05"></a> (SSD-type calibration) or SAD = 100 cm (SAD-type calibration).</li>
    <li>Calibration of an electron beam is performed at a reference depth <span class="italic">d</span><sub>ref</sub> given by <span class="italic">d</span><sub>ref</sub> = 0.6 <span class="italic">R</span><sub>50</sub> − 0.1. It is then converted to dose at <span class="italic">D</span><sub>max</sub> by using percent depth dose at <span class="italic">d</span><sub>ref</sub>. Calibration is set to give <span class="italic">D</span><sub>max</sub>/MU close to unity for a 10 × 10-cm field size (reference applicator) at SSD = 100 cm.</li>
    <li>The basic equation for calibration of photon<a id="GBS.0257.01"></a> and electron beams is <a href="#Gibbons-ch008-equat047">Equation 8.47</a>.</li>
    <li>The difference in measured dose between TG-21 and TG-51 is less than 2% for photons but can be as much as 5% for electron beams.</li>
    </ul>
    </li>
    <li>IAEA TRS-398<ul class="keypoint-list">
    <li>There are minor differences between TG-51 and IAEA TRS-398; for example, beam quality specification in TRS-398 is by TPR<sub>20,10</sub> instead of %dd(10)<sub><span class="italic">x</span></sub>.</li>
    <li>The basic equation for calibration of photon and electron beams (<a href="#Gibbons-ch008-equat076">Equation 8.76</a><a id="GBS.0257.02"></a>) is the same as for TG-51 except for notation.</li>
    </ul>
    </li>
    <li>Exposure rate constant<ul class="keypoint-list">
    <li>Exposure rate constant is defined as exposure rate from a radioactive source of point size and unit activity at a unit distance. Its unit is R m<sup>2</sup>/h/Ci, which means roentgens per hour at a distance of 1 m from a point source of activity of 1 Ci.</li>
    <li>Exposure rate constant is unique to every radioactive source. It depends on the<a id="GBS.0257.03"></a> photon energies emitted in the decay scheme, their energy absorption coefficients in air, and the number of photons/decay of respective energies.</li>
    </ul>
    </li>
    <li>Absolute dosimeters<ul class="keypoint-list">
    <li>Absolute dosimetry means that the dose is determined from the first principles—without reference to another dosimeter.</li>
    <li>The free-air ionization chamber, specially designed spherical chambers of known volume (e.g., at NIST), the calorimeter,<a id="GBS.0257.04"></a> and the ferrous sulfate (Fricke) dosimeter are examples of absolute dosimeters. They are also called primary standards.</li>
    </ul>
    </li>
    <li>Secondary dosimeters<ul class="keypoint-list">
    <li>Secondary dosimeters require calibration against a primary standard. Examples are thimble chambers and plane-parallel ion chambers. TLDs, diodes, and films are also secondary dosimeters but are used primarily for relative dosimetry. They require calibration<a id="GBS.0257.05"></a> against a calibrated ion chamber as well as appropriate corrections for energy dependence (e.g., with depth) and other conditions that may affect their dose–response characteristics.</li>
    </ul>
    </li>
    <li>TLD<ul class="keypoint-list">
    <li>The most commonly used TLD consists of LiF with a trace amount of impurities (magnesium). It is available in many forms and sizes for use in special dosimetry situations (e.g., powder capsules, extruded rods<a id="GBS.0258.01"></a> or chips, and crystals embedded in Teflon or silicon disks). It is reusable if properly annealed and recalibrated in terms of its dose–response curve.</li>
    <li>TLD response is almost independent of energy in the megavoltage range of photon and electron beams used clinically. However, the dosimeter form and size may affect dosimetry for certain beams and irradiation conditions because of fluence perturbation.</li>
    </ul><a id="GBS.0258.02"></a>
    </li>
    <li>Diodes<ul class="keypoint-list">
    <li>Silicon p–n junction diodes are well suited for relative dosimetry of electron beams, output constancy checks, and in vivo patient dose monitoring.</li>
    <li>Their higher sensitivity, instantaneous response, small size (~0.2 to 0.3 mm<sup>3</sup>), and ruggedness offer special advantages over ionization chambers in certain situations.</li>
    <li><a id="page_136"></a>Their major limitations as dosimeters include energy dependence in photon<a id="GBS.0258.03"></a> beams, directional dependence, thermal effects, and radiation-induced damage with prolonged use. Modern diodes minimize these effects.</li>
    <li>Unlike ion chambers, diodes do not require high-voltage bias to collect ions.</li>
    </ul>
    </li>
    <li>Radiographic film<ul class="keypoint-list">
    <li>Sensitivity of film depends on the size of emulsion grains (crystals of silver bromide) and the quality and type of radiation.</li>
    <li>Slow-speed films (small grain size)<a id="GBS.0258.04"></a> such as Kodak XV-2 and Kodak RPM-2 are suitable for relative dosimetry provided their sensitometric curve (also known as H–D curve) is predetermined in comparison with a calibrated ion chamber. Processing conditions must be standardized. Any air pockets between film and its jacket must be eliminated to avoid artifacts.</li>
    <li>Optical density is given by log<sub>10</sub>(<span class="italic">I</span><sub>0</sub>/<span class="italic">I</span><sub>t</sub>), where <span class="italic">I</span><sub>0</sub> is the amount of light incident<a id="GBS.0258.05"></a> on film and <span class="italic">I</span><sub>t</sub> is the amount of light transmitted through film. It is measured by a densitometer having a light source and a tiny aperture (~1 mm diameter or less).</li>
    <li>Film is well suited for relative dosimetry of electron beams (shows practically no energy dependence). In photon beams, however, it shows significant energy dependence and therefore it is used mostly for portal imaging and quality<a id="GBS.0259.01"></a> assurance procedures such as checking beam alignment, isocentric accuracy, and beam flatness. For measuring dose distributions, photon energy dependence must be taken into account.</li>
    </ul>
    </li>
    <li>Radiochromic film<ul class="keypoint-list">
    <li>Major advantages include almost tissue equivalence, high spatial resolution, large dynamic range (10<sup>−2</sup> to 10<sup>6</sup> cGy), low energy dependence, insensitivity to visible light, and no need for processing.</li>
    <li><a id="GBS.0259.02"></a>It is well suited for dosimetry of brachytherapy sources where the doses and dose gradients close to the sources are very high.</li>
    </ul>
    </li>
    </ul>
    </div>
        </div>
        

    
        <div class="chapter" id="chapter9">
        <h1 class="chapter-title">Chapter 9</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>Tissue equivalence<ul class="bullet1">
    <li>Tissue-equivalent materials or phantoms (with regard to photon beam attenuation and depth dose distribution) must have the same effective atomic number and the same electron density (number of electrons per cubic centimeter) as those of soft tissue. Water, polystyrene, and synthetic plastics such as solid water<a id="GBS.0295.01"></a> are examples of materials that are almost tissue equivalent.</li>
    <li>Anthropomorphic phantoms such as Alderson Radiation Therapy Phantom incorporate materials to simulate body tissues—muscle, bone, lung, and air cavities.</li>
    </ul>
    </li>
    <li>Percent depth dose<ul class="bullet1">
    <li>PDD for photon beams in water (or soft tissue), beyond the depth of maximum dose (<span class="italic">d</span><sub>m</sub>), decreases almost exponentially with depth. It increases with an increase in<a id="GBS.0295.02"></a> beam energy (greater penetration), field size (increased scatter), and SSD (inverse square law effect).</li>
    <li>Mayneord <span class="italic">F</span> factor accounts for change in PDD with SSD but not for change in scatter (e.g., for large field sizes and large depths). In general, it overestimates the increase in PDD with increase in SSD.</li>
    </ul>
    </li>
    <li>Tissue–air ratio<ul class="bullet1">
    <li>TAR, like the PDD, depends on depth, beam energy, field size, and field<a id="GBS.0295.03"></a> shape but is almost independent of SSD.</li>
    <li>TARs have traditionally been used for dose calculation involving low-energy beams (e.g., cobalt-60) and isocentric beam geometry (e.g., rotation therapy or stationary SAD techniques). Current methods of dose calculation use TPRs or TMRs, which have no limitation of beam energy and can be more accurately measured (to be discussed in <a href="Gibbons9781496397522-ch010.xhtml">Chapter 10</a>).</li>
    <li>TARs for<a id="GBS.0295.04"></a> low-energy beams (up to cobalt-60) can be measured directly or calculated from PDD.</li>
    <li>BSF or PSF is the TAR at <span class="italic">d</span><sub>m</sub>. It is a substantial factor for beams in the orthovoltage range (highest values are for beams of ~0.6 mm Cu HVL and can be as much as 1.2–1.4, depending on field size). BSF decreases to a few percent above unity for cobalt-60 and approaches unity for higher-energy x-ray beams.</li>
    <li>BSF, like<a id="GBS.0295.05"></a> the TAR, is no longer used in dosimetry of megavoltage beams except for a few institutions where it is still used as a “dummy variable” (to be discussed in <a href="Gibbons9781496397522-ch010.xhtml">Chapter 10</a>).</li>
    <li>SAR represents the scatter component of TAR. It is a useful concept for the dosimetry of irregularly shaped fields (e.g., Clarkson technique). Like the TAR, this quantity may be used for cobalt-60 or lower-energy beams.</li>
    </ul>
    </li>
    <li>Field<a id="GBS.0296.01"></a> equivalence<ul class="bullet1">
    <li>Rectangular, square, and circular fields of photon beams may be equated approximately in terms of dose output and depth dose distribution by using published tables or by equating <span class="italic">A/P</span> (area over perimeter). For example, for a given rectangular field of area <span class="italic">A</span> and perimeter <span class="italic">P</span>:
    <p class="image" id="Gibbons-ch009-unequat011"><img alt="" src="data:image/jpeg;base64,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"/><a id="GBS.0296.02"></a></p></li>
    <li>The <span class="italic">A/P</span> method is not valid for fields of irregular shape.</li>
    </ul></li></ul>
    </div>
        </div>
        

    
        <div class="chapter" id="chapter10">
        <h1 class="chapter-title">Chapter 10</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>TARs and BSFs (or peak scatter factors [PSFs]) are OK to be used for low-energy beams (up to cobalt-60) but they cannot be measured accurately for high-energy beams. They are superseded by TMRs (or TPRs) and the related output factors <span class="italic">S</span><sub>c</sub> and <span class="italic">S</span><sub>p</sub>, which have no limitations of energy.</li>
    <li>Dosimetric quantities for the calculation of dose/MU include PDD, TMR (or TPR), <span class="italic">S</span><sub>c</sub>, <span class="italic">S</span><sub>p</sub>, and distance<a id="GBS.0328.03"></a> factors pertaining to whether the beam bears an SSD calibration or SAD calibration. Assuming SAD = 100 cm, the SSD calibration has the phantom surface at 100 cm, in which case the point of calibration is at (100 + <span class="italic">d</span><sub>max</sub>). In the SAD calibration, the point of calibration is at 100 cm, whereas the phantom surface is at (100 − <span class="italic">d</span><sub>max</sub>). The depth <span class="italic">d</span><sub>max</sub> in all cases is the reference <span class="italic">d</span><sub>max</sub>.</li>
    <li><span class="italic">S</span><sub>c</sub> and <span class="italic">S</span><sub>p</sub>, respectively,<a id="GBS.0328.04"></a> pertain to the collimator-defined field and the field actually irradiating the phantom.</li>
    <li>TMR is a special case of TPR in which the reference depth is a fixed reference <span class="italic">d</span><sub>max</sub> for all field sizes. The reference <span class="italic">d</span><sub>max</sub> is chosen to be for a small field size (e.g., 3 × 3 cm<sup>2</sup>) to minimize the influence of electron contamination.</li>
    <li>Whereas PDDs depend on SSD, TMRs and TPRs are almost independent of SSD.</li>
    <li><a id="GBS.0328.05"></a>TMRs and TPRs can be directly measured in a water phantom or calculated from measured PDDs.</li>
    <li>SMRs and SPRs represent the scatter part of TMRs and TPRs, respectively, and can be used to calculate scattered dose in an irregularly shaped field using Clarkson’s technique.</li>
    <li>Calculation of dose at an off-axis point or in an asymmetric field requires POAR (also called off-center ratio) at the point of calculation.</li>
    </ul><a id="GBS.0329.01"></a>
    </div>
        </div>
        

    
        <div class="chapter" id="chapter11">
        <h1 class="chapter-title">Chapter 11</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>Dose distribution<a id="GBS.0371.03"></a> in the penumbra zone is governed by geometric penumbra, transmission penumbra, and the lateral scatter of photons and electrons. The composite of these effects is represented by what is called as the physical penumbra.</li>
    <li>The dose at the geometric field borders is approximately 50% of the dose at the central axis at the same depth.</li>
    <li>Wedge angle is defined as the angle between an isodose curve at a<a id="GBS.0371.04"></a> specified depth (e.g., 10 cm) and a line perpendicular to the central axis.</li>
    <li>Parallel opposed beams give rise to greater dose at superficial depths than at the midpoint. The ratio of maximum peripheral dose to midpoint dose is much higher for lower-energy beams than for higher-energy beams.</li>
    <li>Integral dose is the total energy absorbed in the treated volume. It is an interesting concept but so far<a id="GBS.0371.05"></a> it has not been correlated precisely to treatment outcomes.</li>
    <li>Strategically located multiple beams (with or without intensity modulation) are necessary to maximize dose to the target volume and minimize dose to normal structures.</li>
    <li>In a wedge-pair technique, there is an optimum relationship between wedge angle θ and the hinge angle γ:
    <p class="image" id="Gibbons-ch011-unequat004"><img alt="" src="data:image/jpeg;base64,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"/><a id="GBS.0372.01"></a></p>
    <p class="noindent">The above equation does not account for surface irregularity and, therefore, should be modified based on the computer treatment plan.</p></li>
    <li>A treatment plan must show, at a minimum, PTV and OR with suitable margins. Other volumes such as the GTV, CTV, and ITV are useful in evaluating a treatment plan.</li>
    <li>An internationally standardized system of dose specification (e.g., ICRU Report 50 and 62) must be<a id="GBS.0372.02"></a> followed in reporting dosages in the patient’s chart as well as in the literature.</li>
    </ul>
    </div>
        </div>
        

    
        <div class="chapter" id="chapter12">
        <h1 class="chapter-title">Chapter 12</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>Treatment planning requires accurate patient data acquisition such as external body contours and internal anatomy.</li>
    <li>Manual devices for body contouring consist of solder wires, pantograph-type contour plotters, and electromechanical devices. Current methods primarily<a id="GBS.0439.01"></a> use CT scans for contour information.</li>
    <li>CT numbers bear a linear relationship with attenuation coefficients.</li>
    <li>CT numbers depend on electron density (electrons per cubic centimeter) as well as atomic number, if the scanning beam used is kilovoltage x-rays as in conventional CT scanners.</li>
    <li>Correlation between CT numbers and electron density of various tissues is established by scanning phantoms of known<a id="GBS.0439.02"></a> electron densities in the range that includes lung, muscle, and bone.</li>
    <li>Imaging modalities such as ultrasound, MRI, and PET are useful in mapping out structural and/or functional anatomy, but their signal values are not correlated with electron density. Fusion techniques are used to combine their images with the corresponding CT images to provide geometric accuracy of external contour and internal<a id="GBS.0439.03"></a> anatomy.</li>
    </ul>
    <ul class="keypoint-list">
    <li><a id="page_239"></a>Radiographic and/or CT simulators are an essential part of the treatment-planning process.</li>
    <li>Accelerator-mounted accessories such as EPID and CBCT systems allow treatment verification before and during treatments. These capabilities are essential when using conformal radiation therapy techniques such as 3-D CRT or intensity-modulated radiation therapy (IMRT).</li>
    <li>Manual methods of contour<a id="GBS.0439.04"></a> and tissue heterogeneity corrections are semiempirical and have given way to computer algorithms for treatment planning. These are collectively called correction-based algorithms. Currently, the most sophisticated algorithms are model based (e.g., pencil beam, convolution/superposition, and semi-Monte Carlo techniques).</li>
    <li>Dose within bone depends on beam energy.</li>
    <li>Dose to soft tissue within bone is<a id="GBS.0439.05"></a> two to five times higher in the orthovoltage and superficial range of beam energies. It is about 3% to 10% higher in the megavoltage range used clinically (<a href="#Gibbons-ch012-tbl005">Table 12.5</a>).</li>
    <li>Dose reduction can occur at air cavity surfaces and lung because of a partial loss of electronic equilibrium. The effect is more pronounced for small fields (&lt;6 × 6 cm<sup>2</sup>) and high-energy beams (&gt;6 MV).</li>
    <li>Compensators are used to compensate<a id="GBS.0440.01"></a> for missing tissue at the surface or internal inhomogeneities such as lung. Their design takes into account the extent of missing tissue, compensator to surface distance (or thickness ratio), and the density of the compensator material.</li>
    <li>Reproducible and stable patient positioning; proper immobilization; accurate measurements of external and internal bony landmarks; precise <span class="italic">X</span>, <span class="italic">Y</span>, <span class="italic">Z</span> couch motions;<a id="GBS.0440.02"></a> and isocentric accuracy are crucial requirements for precision radiotherapy.</li>
    </ul></div>
        </div>
        

    
        <div class="chapter" id="chapter13">
        <h1 class="chapter-title">Chapter 13</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>Thickness of lead required to give 5% primary<a id="GBS.0479.02"></a> beam transmission is 4.3 half-value layers.</li>
    <li>Half-beam blocking gives rise to tilting of the isodose curves toward the blocked edge. This effect is due to missing electron and photon scatter from the blocked part of the field into the open part of the field.</li>
    <li>Physical penumbra with a rounded-end MLC is wider than that with the collimator jaws or Cerrobend blocks.</li>
    <li>Surface dose in megavoltage beams<a id="GBS.0479.03"></a> is predominantly due to the electron contamination of the incident photon beam.</li>
    <li>Dose at the surface or in the buildup region is best measured with an extrapolation or a plane-parallel chamber.</li>
    <li>Surface dose depends on beam energy, field size, SSD, and tray to surface distance.</li>
    <li>Electron filters are medium-atomic-number absorbers (<span class="italic">Z</span> ~ 50) that reduce the surface dose by scattering contaminant electrons<a id="GBS.0479.04"></a> more than generating them.</li>
    <li>Surface dose increases with increasing angle of obliquity.</li>
    <li>Separation of adjacent fields, when needed, may be accomplished geometrically. Hot and cold spots in the resultant dose distribution must be assessed by viewing composite isodose curves.</li>
    </ul>
    </div>
        </div>
        

    
        <div class="chapter" id="chapter14">
        <h1 class="chapter-title">Chapter 14</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>The clinically useful energy range of electrons is 6 to 20 MeV. At these energies, electron beams can be used for treating superficial tumors (&lt;5 cm deep).</li>
    <li>Electrons interact with matter<a id="GBS.0571.01"></a> by (a) ionization and excitation—the most predominant interaction in soft tissues, (b) bremsstrahlung—more significant at higher energies and in higher-atomic-number materials, (c) elastic scattering by atomic nuclei, and (d) elastic scattering by orbital electrons. Collisions resulting in secondary electron production (Δ-rays) are possible but rare.</li>
    <li>Energy of clinical electron beams is specified<a id="GBS.0571.02"></a> by the <span class="italic">most probable energy at the surface</span>.</li>
    <li>The rate of energy loss with depth in water (or soft tissue) for clinical electron beams is approximately 2 MeV/cm.</li>
    <li>Electron beams have a modest skin-sparing effect, which gradually disappears with increasing energies.</li>
    <li>The lower the energy, the sharper is the dose drop-off beyond the therapeutic range.</li>
    <li>Depth dose distribution can be determined by ion<a id="GBS.0571.03"></a> chambers, diodes, and film.</li>
    <li>Percent surface dose increases with increase in energy.</li>
    <li>Electron applicators are necessary to collimate the beam close to the patient surface.</li>
    <li>Acceptable beam flatness is achieved by dual scattering foils.</li>
    <li>PDD and output vary with field size if the field size is smaller than that required for LSE.</li>
    <li>Virtual SSD determines beam divergence. Effective SSD gives agreement<a id="GBS.0571.04"></a> with inverse square law.</li>
    <li>Beam obliquity changes the PDD, giving rise to increase in dose at <span class="italic">d</span><sub>max</sub> and decrease in depth dose beyond.</li>
    <li>Steep changes in surface contour give rise to “hot” and “cold” spots.</li>
    <li><a id="page_315"></a>For large slabs of inhomogeneities, PDD corrections can be made using CET or effective depth based on electron density (number of electrons per cubic centimeter relative to water).</li>
    <li>Around small<a id="GBS.0571.05"></a> inhomogeneities and at the steep edges of heterogeneities, electron scatter gives rise to “hot” and “cold” spots.</li>
    <li>Adjacent electron–electron or electron–photon fields give rise to “hot” and “cold” spots because of beam divergence and interfield electron scattering, respectively.</li>
    <li>Bolus may be used to build up surface dose, decrease beam energy, or conform the dose distribution to the PTV. In any<a id="GBS.0572.01"></a> case, bolus must be placed directly on the skin surface.</li>
    <li>Field shaping can be done with lead or Cerrobend cutouts.</li>
    <li>Minimum thickness of lead required for 5% transmission of dose is approximately <span class="italic">E</span>/2 in millimeters of lead, where <span class="italic">E</span> is the beam energy in MeV incident on lead.</li>
    <li>Internal shielding is possible in some cases, but dose enhancement because of backscatter from lead must be taken into account.</li>
    <li><a id="GBS.0572.02"></a>Electron arc therapy is feasible for tumors along curved surfaces, but custom shielding (molded on to the surface) is required to define the treatment field and sharpen dose distribution at the field edges.</li>
    <li>Total skin electron irradiation is a useful technique for the treatment of mycosis fungoides. Considerable dosimetry is required before commissioning the procedure for actual treatments.</li>
    <li>Pencil<a id="GBS.0572.03"></a> beam algorithms, based on multiple scattering theory, are currently the algorithms of choice for electron beam treatment planning.</li>
    </ul></div>
        </div>
        

    
        <div class="chapter" id="chapter15">
        <h1 class="chapter-title">Chapter 15</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>Decay of radium-226 to stable lead produces 49 individual γ-rays, ranging in energy from 0.18 to 2.5 MeV.</li>
    <li>Exposure rate constant for radium filtered by 0.5 mm platinum is 8.25 R-cm<sup>2</sup>/h/mg.</li>
    <li>Most<a id="GBS.0645.04"></a> commonly used sources in modern brachytherapy are cesium-137, iridium-192, iodine-125, and palladium-103.</li>
    <li>The AAPM recommends specification of brachytherapy sources in terms of <span class="italic">air kerma strength</span> in units of μGy-m<sup>2</sup>/h.</li>
    <li>Brachytherapy sources may be calibrated with a well-type ion chamber, using exposure-calibrated standard sources of the same kind and design.</li>
    <li>Dose distribution around brachytherapy<a id="GBS.0645.05"></a> sources, at distances of clinical interest, is predominantly governed by inverse square law, irrespective of photon energy.</li>
    <li>Exposure rate around a linear brachytherapy source (clad in a uniformly thick filter) can be calculated using <span class="italic">Sievert integral</span>. The integral involves air kerma strength, active length, filter thickness, and effective attenuation coefficient for the filter. This algorithm<a id="GBS.0646.01"></a> has been traditionally used for radium-226, cesium-137, and iridium-192 sources.</li>
    <li>The TG-43 dose calculation model involves dose rate constant for the source, air kerma strength, geometry factor, anisotropy factor, and radial function. This algorithm is especially suited for iodine-125, palladium-103, and iridium-192 seeds. TG-43 has been updated to TG-43U1.</li>
    <li>The Paterson–Parker system is designed<a id="GBS.0646.02"></a> to implant sources of varying strength and configuration (Paterson–Parker rules of implant) in order to deliver a uniform dose (within ±10%) to a specified plane or volume.</li>
    <li>The Quimby system is characterized by a uniform distribution of sources of equal linear activity. It results in a higher dose in the middle of the implant. Dose specification for a Quimby implant is different from that for<a id="GBS.0646.03"></a> the Paterson–Parker system.</li>
    <li>The Paris system is designed for removable implants of long line sources such as Ir-192.</li>
    <li>The computer system is similar to the Paris system except for dose specification.</li>
    <li>Intracavitary brachytherapy is designed to hold sources (e.g., Cs-137 tubes) in a fixed geometry using applicators (e.g., tandem and ovoids).</li>
    <li>The ICRU system of dose specification and reporting is<a id="GBS.0646.04"></a> recommended for intracavitary brachytherapy.</li>
    <li>HDR brachytherapy has advantages and disadvantages that must be considered before it is implemented.</li>
    </ul></div>
        </div>
        

    
        <div class="chapter" id="chapter16">
        <h1 class="chapter-title">Chapter 16</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>The dosimetric<a id="GBS.0697.04"></a> quantity relevant to radiation protection is the <span class="italic">dose equivalent</span> (= dose × quality factor).</li>
    <li><span class="italic">Effective dose equivalent</span> is “the sum of the weighted dose equivalents for individual tissues or organs.”</li>
    <li>Effective dose equivalent for background radiation in the United States is approximately 3 mSv/y (300 mrem/y).</li>
    <li>Harmful effects of ionizing radiation are classified as <span class="italic">stochastic</span> (all-or-none phenomenon)<a id="GBS.0697.05"></a> and <span class="italic">nonstochastic</span> (severity depending on dose).</li>
    <li>Effective dose-equivalent limits for occupational and general population exposures have been recommended by the NCRP.</li>
    <li>The <span class="italic">ALARA</span> principle requires that the risks be kept “as low as reasonably achievable,” taking into account social and economic factors.</li>
    <li>In structural shielding, adequacy of barriers should take into account <span class="italic">workload</span>, <span class="italic">use factor</span>, and<a id="GBS.0698.01"></a> <span class="italic">occupancy factor.</span></li>
    <li>Wall barrier, door, and maze design should also allow for protection against neutron contamination for accelerators operating at energies greater than 10 MV.</li>
    <li>Protection against radiation from brachytherapy sources involves shielded drawers for storage, shielded barriers for source preparation, shielded pigs and carts for source transportation, and directly filtered exhausts to<a id="GBS.0698.02"></a> the outdoors.</li>
    <li>A source is considered to be leaking if a presence of 0.005 μCi or more of removable contamination is measured.</li>
    <li>Large-volume ion chambers (e.g., Cutie Pie) are suitable for measuring low-level x- or γ radiation if they are properly calibrated. They are not suitable for measuring neutrons.</li>
    <li>Low levels of neutrons can be measured by calibrated rem meters (BF<sub>3</sub> counters).</li>
    <li>G-M counters<a id="GBS.0698.03"></a> are primarily used for radiation detection.</li>
    <li>Equipment surveys are required to check design specifications including patient and personnel safety and limits on leakage radiation through the source housing.</li>
    <li>Area surveys are required to check environmental safety. They should be evaluated by taking into account actual operating conditions, workload, use factor, occupancy factor, and attenuation and<a id="GBS.0698.04"></a> scattering of the useful beam by the patient.</li>
    <li>Use of all reactor-produced radioactive materials (by-product materials) in the United States is under the control of the NRC. As of November 30, 2007, use of accelerator-produced radioactive material or discrete sources of radium-226 must also comply with the requirements of the NRC.</li>
    <li>Use of x-ray machines is regulated by individual states.</li>
    <li><span class="italic">Agreement<a id="GBS.0698.05"></a> states</span> are allowed to enforce NRC regulations.</li>
    <li>NRC regulations that govern the medical use of by-product materials are contained in the Code of Federal Regulations, 10 CFR Part 35. They are revised from time to time. A licensee must abide by the most current regulations in force.</li>
    </ul>
    </div>
        </div>
        

    
        <div class="chapter" id="chapter17">
        <h1 class="chapter-title">Chapter 17</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>The ACR <span class="italic">Blue Book</span> provides recommendations with regard to equipment and staffing needs based on patient load. These guidelines were recently updated to keep pace with the development of new technologies and treatment methodologies such as 3-D conformal radiation<a id="GBS.0763.01"></a> therapy, standard radiation therapy, IMRT, IGRT, and HDR brachytherapy.</li>
    <li>Radiation therapy equipment must be tested and commissioned using nationally approved protocols (e.g., relevant AAPM protocols).</li>
    <li>Each radiation therapy institution (no matter how big or small) is expected to have a QA program that meets national/international standards.</li>
    <li>A QA program should be reviewed on a regular basis (at<a id="GBS.0763.02"></a> least annually) to incorporate recommendations of new protocols, the user’s experience, and experience of other users.</li>
    </ul>
    </div>
        </div>
        

    
        <div class="chapter" id="chapter18">
        <h1 class="chapter-title">Chapter 18</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>TBI is used as a conditioning regimen for bone marrow transplantation for<a id="GBS.0780.03"></a> a variety of diseases.</li>
    <li>The choice of beam energy is dictated by patient thickness and the specification of dose homogeneity in the TBI protocols.</li>
    <li>Beam spoiler in TBI is used to build up the surface dose to at least 90% of the prescribed TBI dose.</li>
    <li>Compensators are required to achieve dose homogeneity of ±10%, excluding extremities.</li>
    <li>Dose/MU can be calculated using standard parameters such as TMRs,<a id="GBS.0780.04"></a> output factors, inverse square law, off-axis ratios, and transmission factors for attenuators in the path of the beam. The formalism must be verified for the TBI conditions using appropriate phantoms and in vivo patient measurements.</li>
    <li>TBI techniques are designed to follow approved protocols specifying many different regimens: single fraction with low dose rate, single fraction with high dose rate,<a id="GBS.0780.05"></a> fractionated TBI, hyperfractionated TBI, AP/PA technique, bilateral technique, use or no use of compensators, blocking or no blocking of critical organs, and so on. TBI regimens have a general biologic rationale, but the specific techniques are mostly empirical based.</li>
    </ul>
    </div>
        </div>
        

    
        <div class="chapter" id="chapter19">
        <h1 class="chapter-title">Chapter 19</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>3-D CRT requires anatomic information in three dimensions. It is provided by imaging modalities such as CT, MRI, US, SPECT, and<a id="GBS.0807.04"></a> PET.</li>
    <li>Essential features of 3-D CRT treatment planning include image registration, image segmentation, BEV design of treatment fields, and plan evaluation.</li>
    <li>DVHs, along with the isodose curves and isodose surfaces, are essential tools for plan evaluation.</li>
    <li>Dose calculation algorithms fall into three broad categories: (a) correction based, (b) model based, and (c) direct MC.</li>
    <li>Convolution-superposition<a id="GBS.0807.05"></a> is currently the most accurate model-based algorithm.</li>
    <li>The convolution kernel is a dose spread array that is obtained by measurement or calculation using an MC code.</li>
    <li>Direct MC is the most accurate method for treatment planning, but currently it is not feasible because it requires prohibitively long computational times. However, with the continuing advancement of computer technology, it is possible<a id="GBS.0808.01"></a> that direct MC will be used routinely for treatment planning in the not too distant future.</li>
    </ul>
    </div>
        </div>
        

    
        <div class="chapter" id="chapter20">
        <h1 class="chapter-title">Chapter 20</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>IMRT requires at least two systems in addition to the conventional linear accelerator: (a) computer TPS with IMRT software and (b) beam delivery system capable of nonuniform fluences as required by IMRT software.</li>
    <li>Inverse planning algorithms with plan optimization techniques such as simulated annealing are best suited for IMRT treatment<a id="GBS.0852.05"></a> planning.</li>
    <li>Most IMRT beam delivery is accomplished by either of the two techniques: (a) using MLC as intensity modulator or (b) tomotherapy (slice by slice or helical) analogous to CT scanning, using a special collimator for intensity modulation.</li>
    <li>Clinical implementation of IMRT requires checks of beam delivery, treatment planning, and a rigorous QA program. Some of the commissioning procedures<a id="GBS.0852.06"></a> and QA tests are discussed in this chapter.</li>
    </ul>
    </div>
        </div>
        

    
        <div class="chapter" id="chapter21">
        <h1 class="chapter-title">Chapter 21</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>Intracranial SRS or SRT techniques involve a stereotactic apparatus<a id="GBS.0877.04"></a> to immobilize the head and the delivery of radiation through multiple noncoplanar beams or arcs.</li>
    <li>An overall accuracy of ±1 mm in the coverage of the intended target volume is a commonly accepted standard for the SRS and SRT procedures.</li>
    <li>Dosimetry of small fields as used in SRS or SRT is complex because of a possible lack of charged particle equilibrium. The detector must be of a sufficiently small<a id="GBS.0877.05"></a> size so as not to perturb the electron fluence. Any energy dependence must also be accounted for.</li>
    <li>SRS requires careful commissioning and rigorous QA procedures.</li>
    <li>Extracranial SRS or stereotactic body radiation therapy procedures are frameless and rely on robotic image-guided radiation therapy techniques such as Exactrac and CyberKnife.</li>
    </ul>
    </div>
        </div>
        

    
        <div class="chapter" id="chapter22">
        <h1 class="chapter-title">Chapter 22</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>SBRT is an external beam radiation therapy method used to deliver an ultrahigh dose of radiation to an extracranial target.</li>
    <li>Early SBRT treatment deliveries used body frames with independent stereotactic coordinate systems to immobilize patients. These have largely been replaced with more conventional<a id="GBS.0894.03"></a> immobilization combined with pretreatment IGRT position verification.</li>
    <li>Lung tumor motion may be accounted for by using 4DCT scanning. 4DCT scanning produces a set of CT images corresponding to the phase of the respiratory cycle. For lung lesions, the ITV is drawn from the maximum intensity projection, or MIP image.</li>
    <li>Target motion may be physically reduced with abdominal compression devices or breath-hold<a id="GBS.0894.04"></a> techniques.</li>
    <li>Dose calculations for SBRT in the lung should be made on treatment planning systems capable of determining doses near the lung–tissue interface. 3-D algorithms such as convolution–superposition and Monte Carlo are recommended.</li>
    <li>The biologic effects of SBRT dose fractionations are very high—ranging to over twice that of conventional fractionation schemes.</li>
    <li>The recommended quality assurance<a id="GBS.0894.05"></a> tolerances for SBRT are tighter than those for conventional radiation therapy. The specific requirements are contained in the AAPM TG 142 report.</li>
    </ul></div>
        </div>
        

    
        <div class="chapter" id="chapter23">
        <h1 class="chapter-title">Chapter 23</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>HDR is classified as a brachytherapy procedure with prescription dose rates of 20 cGy/min or higher.</li>
    <li>Most HDR units contain a single <sup>192</sup>Ir source: diameter 0.3 to 0.6 mm, length 3.5 to 10 mm, and activity ~10 Ci.</li>
    <li>HDR is used for intracavitary as well as interstitial implants.</li>
    <li>The<a id="GBS.0924.02"></a> HDR unit must be housed in an adequately shielded room so that the public and occupational exposures do not exceed the NRC-approved limits.</li>
    <li><a id="page_501"></a>The NRC licensing requirements for HDR include:
    <ul class="bullet1">
    <li>Written procedures concerning all aspects of the treatment (e.g., written directive, patient identification, plan verification, pretreatment QA, treatment delivery, posttreatment survey, source placement and<a id="GBS.0924.03"></a> calibration checks, recording of treatment administered, treatment supervision, identification of a medical event, periodic QA, and annual reviews)</li>
    <li>Pretreatment safety checks</li>
    <li>HDR operating procedures</li>
    <li>Emergency procedures</li>
    </ul></li>
    <li>The HDR source must be calibrated at each installation. This calibration must be traceable to the NIST.</li>
    <li>Commissioning and QA of the HDR unit and the treatment-planning system<a id="GBS.0924.04"></a> must meet the current standards of national guidelines and the NRC licensing requirements.</li>
    <li>HDR has the potential to replace LDR for practical reasons if not clinical.</li>
    </ul></div>
        </div>
        

    
        <div class="chapter" id="chapter24">
        <h1 class="chapter-title">Chapter 24</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>Permanent implants with iodine-125 or palladium-103 seeds are used in the treatment of early-stage prostate cancer.</li>
    <li>The prostate implant procedure involves:
    <ul class="bullet1">
    <li>Volume study using a<a id="GBS.0940.05"></a> transrectal ultrasound probe</li>
    <li>Pretreatment planning and design of template for seed placement</li>
    <li>Implantation of seeds in the operating room using ultrasound probe and template guidance</li>
    <li>Postimplant dosimetry using CT scans</li>
    </ul>
    </li>
    <li>In general, seeds are planned for implantation with interseed spacing of 1 cm (center to center). Individual seeds are added or deleted to optimize isodose coverage of the target<a id="GBS.0941.01"></a> volume (prostate gland) while sparing the organs at risk (rectum and urethra).</li>
    <li>Isodose distribution and DVHs for the target, rectum, and urethra are the essential tools for treatment-plan evaluation.</li>
    <li>The treatment-planning system must be formally commissioned by using appropriate source data and relevant protocols. Computer dosimetry should be checked by manual calculations using simulated implants.</li>
    <li><a id="GBS.0941.02"></a>A random sample of seeds should be assayed to check the vendor-supplied calibration.</li>
    <li>A quality assurance program that meets national guidelines (e.g., AAPM protocol) and the mandated NRC requirements must be instituted and implemented.</li>
    </ul>
    </div>
        </div>
        

    
        <div class="chapter" id="chapter25">
        <h1 class="chapter-title">Chapter 25</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>IVBT significantly lowers the rate of neointimal formation, thereby reducing the risk of restenosis.</li>
    <li>The target volume for IVBT is typically 2 to 5 cm in length of<a id="GBS.0959.04"></a> artery and 0.5 to 2 mm of arterial wall.</li>
    <li>The AAPM-recommended depth of dose prescription is 2 mm from the center of the source for intracoronary irradiation. For the peripheral arteries, it is 2 mm beyond the average lumen radius.</li>
    <li>HDR (e.g., 5 Gy/min or greater) β sources are preferable for IVBT over γ sources.</li>
    <li>Catheter-based radiation delivery systems are preferable over β-emitting liquid-filled<a id="GBS.0959.05"></a> balloons or radioactive stents.</li>
    <li><a id="page_521"></a>The AAPM TG-43 formalism (with the TG-149 update) is suitable for catheter-based IVBT dose calculations. Different algorithms are required for liquid-filled balloons or radioactive stents.</li>
    <li>The AAPM protocol recommends the calibration of IVBT sources at a distance of 2 mm from the center of the source.</li>
    <li>An IVBT QA program must be instituted and implemented in accordance<a id="GBS.0960.01"></a> with the national protocol guidelines (e.g., AAPM TG-60) and the mandatory requirements of the NRC license.</li>
    <li>Current trends favor DESs. However, IVBT still has a role in lowering the incidence of restenosis, with or without DESs.</li>
    </ul>
    </div>
        </div>
        

    
        <div class="chapter" id="chapter26">
        <h1 class="chapter-title">Chapter 26</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>Image guidance technologies used in IGRT include accelerator-mounted kV imagers as well as imaging equipment accessible in the treatment room.</li>
    <li>On-board kV images can be used in both the<a id="GBS.0993.03"></a> radiographic and fluoroscopic modes to check patient setup before each treatment and track motion of anatomy or implanted fiducial markers during treatment.</li>
    <li>kV imagers have better soft-tissue contrast than the MV imagers. However, the MV images are free from streaking artifacts caused by metallic objects and bear direct correlation between CT numbers and electron density of tissues—a feature that<a id="GBS.0993.04"></a> is helpful in dosimetry.</li>
    <li>The MV imagers are also useful in portal verification before and during treatment, using images of internal bony anatomy.</li>
    <li>Comparison of kVCBCT and MVCBCT shows that each has its own advantages and disadvantages. However, the two modalities are often complementary.</li>
    <li>Helical tomotherapy is an IMRT delivery technique that combines features of a linear accelerator and a helical<a id="GBS.0993.05"></a> CT scanner.</li>
    <li>Basic problems with the use of ultrasound for IGRT are (a) poor image quality and (b) anatomic distortions caused by the transducer pressure on the patient surface.</li>
    <li>Management of respiratory motion in IGRT is an evolving field. Noteworthy developments include 4-D CT and real-time tumor-tracking systems such as fluoroscopy-based systems, the ExacTrac/Novalis Body system, CyberKnife,<a id="GBS.0994.01"></a> electromagnetic field tracking, and MRI-guided radiation therapy.</li>
    <li>Excessive dose from intensive imaging procedures is a serious problem in IGRT. There is a need to evaluate stochastic as well as nonstochastic risks involved in all the imaging procedures used in radiation therapy. Imaging doses must be balanced with demonstrable improvements in the delivery of therapeutic dose.</li>
    </ul></div>
        </div>
        

    
        <div class="chapter" id="chapter27">
        <h1 class="chapter-title">Chapter 27</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>Currently, proton accelerators for use in radiotherapy are<a id="GBS.1028.05"></a> cyclotrons and synchrotrons. Cyclotrons operate at a fixed energy, which can be modulated by the use of energy degraders to create SOBP at any depth. Synchrotrons produce beams of variable energy and can generate any desired energy without the use of energy degraders.</li>
    <li>New technologies are being considered to reduce the size of the accelerator and/or improve its performance and reliability for<a id="GBS.1029.01"></a> clinical use. Two examples are high-gradient electrostatic accelerators and laser plasma particle accelerators.</li>
    <li>High-energy protons interact with matter by (a) inelastic collisions (with loss of energy) and (b) elastic collisions or scattering (without loss of energy). Inelastic collisions consist of predominantly ionization and excitation of atoms, some nuclear reactions, and very little (almost<a id="GBS.1029.02"></a> negligible) bremsstrahlung. Elastic scattering is predominantly through Coulomb interactions with atomic nuclei.</li>
    <li>Stopping power (energy loss per unit path length or <span class="italic">dE</span>/<span class="italic">dx</span>) for protons is inversely related to the square of their velocity.</li>
    <li>Protons deliver maximum dose near the end of their range, thus giving rise to what is called the Bragg peak.</li>
    <li>Pristine proton beams are modulated in energy and<a id="GBS.1029.03"></a> intensity to create SOBP beams for the treatment of tumor at any depth.</li>
    <li>RBE depends on LET, which increases with decrease in proton energy and is greatest at the Bragg peak. However, a universal RBE of 1.1 for proton beams has been adopted for practical reasons.</li>
    <li>Beam delivery systems to produce uniform fields of any size vary between different accelerators and are mainly of two types: passive<a id="GBS.1029.04"></a> beam spreading and PB scanning.</li>
    <li>The current protocol for the absorbed dose calibration of proton beams is the IAEA Report 398.</li>
    <li>Dose calculation algorithms for treatment planning are model based: PB and convolution/superposition. Monte Carlo codes are also available but are too slow for routine treatment planning.</li>
    <li>Proton beam radiotherapy has been used to treat almost all kinds of tumors that are<a id="GBS.1029.05"></a> traditionally treated with x-rays and electrons. Most useful applications are in the treatment of tumors in close vicinity of critical normal structures (e.g., tumors of the brain, eye, and spine).</li>
    <li>IMPT gives dose conformity comparable to IMRT but with much less integral dose.</li>
    <li>QA programs should be developed based on national/international protocols as well as institutional policies and procedures<a id="GBS.1030.01"></a> for effective and safe use of radiation therapy.</li>
    </ul>
    </div>
        </div>
        

    
        <div class="chapter" id="chapter28">
        <h1 class="chapter-title">Chapter 28</h1>
        
        <div class="content-section">
    <ul class="keypoint-list">
    <li>Studies have shown that there is a significant variability among the quality of manually constructed treatment plans and that this variability is correlated with the experience of key personnel.</li>
    <li>Knowledge-based planning in radiation oncology may be broadly divided into atlas-based and model-based approaches. Atlas-based approaches contain a database<a id="GBS.1043.03"></a> of previously treated patients for comparison; model-based algorithms determine a relationship between patient anatomic parameters and their resulting DVHs and apply this to new treatment plans.</li>
    <li>Knowledge-based treatment planning requires training a machine learning algorithm with a few high-quality cases. These cases must be clinically validated to prevent the algorithm from optimizing some parameters<a id="GBS.1043.04"></a> to the detriment of others.</li>
    <li>A number of different machine learning algorithms such as PCA have been used to determine correlations between patient anatomic parameters to optimal DVH for treatment plans.</li>
    </ul>
    </div>
        </div>
        

    
  <button class="floating-btn" onclick="toggleTableOfContents()"><i class="fas fa-list"></i></button>
  <a href="index.html" class="home-btn"><i class="fas fa-home"></i></a>
  <button class="theme-toggle" id="themeToggle"><i class="fas fa-moon"></i></button>

  <script>
    // JavaScript function to toggle the visibility of the table of contents
    function toggleTableOfContents() {
      var toc = document.getElementById('table-of-contents');
      if (toc.style.display === 'none' || toc.style.display === '') {
        toc.style.display = 'block';
      } else {
        toc.style.display = 'none';
      }
    }

    // Theme Toggle
    const themeToggle = document.getElementById('themeToggle');
    
    themeToggle.addEventListener('click', () => {
      const html = document.documentElement;
      const currentTheme = html.getAttribute('data-theme');
      const newTheme = currentTheme === 'dark' ? 'light' : 'dark';
      
      html.setAttribute('data-theme', newTheme);
      
      // Update theme toggle icon
      const themeIcon = themeToggle.querySelector('i');
      if (newTheme === 'dark') {
        themeIcon.className = 'fas fa-moon';
      } else {
        themeIcon.className = 'fas fa-sun';
      }
      
      // Save theme preference
      localStorage.setItem('theme', newTheme);
    });

    // Load saved theme
    document.addEventListener('DOMContentLoaded', () => {
      const savedTheme = localStorage.getItem('theme');
      if (savedTheme) {
        document.documentElement.setAttribute('data-theme', savedTheme);
        
        // Update theme toggle icon
        const themeIcon = themeToggle.querySelector('i');
        if (savedTheme === 'dark') {
          themeIcon.className = 'fas fa-moon';
        } else {
          themeIcon.className = 'fas fa-sun';
        }
      }
    });
  </script>
</body>
</html>
